Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
EWTX

Updated 10/6/2026, 8:26 AM ET.

EWTX

Edgewise Therapeutics, Inc.

Sale$412,703

Donovan Joanne M.

CMO

9,441 shat $43.71Filed Aug 14, 4:54 PM ETFiling
EWTX

Edgewise Therapeutics, Inc.

Sale$258,042

Russell Alan J

Chief Scientific Officer, Director

5,901 shat $43.73Filed Aug 14, 4:53 PM ETFiling
EWTX

Edgewise Therapeutics, Inc.

Sale$219,823

MOORE JOHN R

General Counsel

5,016 shat $43.82Filed Aug 14, 4:53 PM ETFiling
EWTX

Edgewise Therapeutics, Inc.

Sale$223,424

Derakhshan Behrad

Chief Business Officer

5,100 shat $43.81Filed Aug 14, 4:53 PM ETFiling
EWTX

Edgewise Therapeutics, Inc.

Sale$785,042

KOCH KEVIN

President and CEO, Director

17,971 shat $43.68Filed Aug 14, 4:52 PM ETFiling

Read from public SEC filings. Not financial advice.